One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Results of a Remotely Delivered Hypertension and Lipid Program in More Than 10 000 Patients Across a Diverse Health Care Network
Alexander J. Blood, MD, MSc; Christopher P. Cannon, MD; William J. Gordon, MD; et al.
doi : 10.1001/jamacardio.2022.4018
January 2023, Vol 8, No. 1, Pages 4-100
Effect of Nudges to Clinicians, Patients, or Both to Increase Statin PrescribingA Cluster Randomized Clinical Trial
Srinath Adusumalli, MD, MSHP, MBMI; Genevieve P. Kanter, PhD; Dylan S. Small, PhD; et al.
Knowledge of Genome Sequencing and Trust in Medical Researchers Among Patients of Different Racial and Ethnic Groups With Idiopathic Dilated Cardiomyopathy
Hanyu Ni, PhD, MPH; Elizabeth Jordan, MMSc; Jinwen Cao, MS; et al.
Initial Thoracic Endovascular Aortic Repair vs Medical Therapy for Acute Uncomplicated Type B Aortic Dissection
E. Hope Weissler, MD, MHS; Oyomoare L. Osazuwa-Peters, PhD; Melissa A. Greiner, MS; et al.
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection FractionA Prespecified Analysis of the DELIVER Randomized Clinical Trial
Finnian R. Mc Causland, MBBCh, MMSc; Brian L. Claggett, PhD; Muthiah Vaduganathan, MD, MPH; et al.
Population-Level Implications of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Preserved Ejection Fraction in the US
Khawaja M. Talha, MBBS; Javed Butler, MD, MPH, MBA; Stephen J. Greene, MD; et al.
Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo
Mark A. Hlatky, MD; Pedro Engel Gonzalez, MD; JoAnn E. Manson, MD, DrPH; et al.
Effect of Smartphone Dispatch of Volunteer Responders on Automated External Defibrillators and Out-of-Hospital Cardiac ArrestsThe SAMBA Randomized Clinical Trial
Ellinor Berglund, RN, PhD; Jacob Hollenberg, MD, PhD; Martin Jonsson, MSc, PhD; et al.
Use of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagonlike Peptide-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Disease in Community Practice
Michael G. Nanna, MD, MHS; Ahmed A. Kolkailah, MD, MSc; Courtney Page, MA; et al.
Geographical and Urban-Rural Disparities in Cardiac Rehabilitation Eligibility and Center-Based Use in the US
Erik H. Van Iterson, PhD; Luke J. Laffin, MD; Dennis Bruemmer, MD, PhD; et al.
Inequities in Access to Structural Heart Disease Interventions
Kriyana Pasham Reddy, BS; Lauren Anne Eberly, MD, MPH; Ashwin Senthil Nathan, MD, MS
Improving Out-of-Hospital Cardiac Arrest Survival Rates—Optimization Given Constraints
Kevin G. Volpp, MD, PhD; Benjamin S. Abella, MD, MPhil
COP27 Climate Change Conference—Urgent Action Needed for Africa and the World
Lukoye Atwoli; Gregory E. Erhabor; Aiah A. Gbakima; et al.
Can System Solutions Be Scaled to Control High Blood Pressure and Lipids?
Neha J. Pagidipati, MD, MPH; Eric D. Peterson, MD, MPH
Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both
Faraz S. Ahmad, MD, MS; Stephen D. Persell, MD
Treatment of Uncomplicated Type B Aortic DissectionThe Devil Is in the Details…Or Is It?
Karen M. Kim, MD; Marion A. Hofmann Bowman, MD, PhD; Kim A. Eagle, MD
Primary Prevention Management of Elevated Lipoprotein(a)
Anandita Agarwala, MD; Christie Ballantyne, MD; Neil J. Stone, MD
Equitable and Informed Consent in Genetic Studies
Ann Marie Navar, MD, MHS, PhD; Sadiya S. Khan, MD, MSc
